Trial Profile
Long-term efficacy of ticagrelor versus prasugrel in patients with acute coronary syndromes.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Jul 2014
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- 28 Jul 2014 New trial record